ESTRO 36 Programme book and exhibition guide

POSTERS

> A predictive nomogram for decision support for patients with pancreatic neuroendocrine tumours A. Jochems, R. Baum (Germany), A. Singh, K. Niepsch, H. Kulkarni, P. Lambin > Reduced inter- and intra-observer variation in esophageal tumour delineation using fiducial markers. M. Machiels (The Netherlands), P. Jin, P. Jelvehgaran, O.J. Gurney-Champion, E.D. Geijsen, P.M. Jeene, M.W. Kolff, V. Oppedijk, M.B. Van Herk, T. Alderliesten, M.C.C.M. Hulshof > Phase II study of induction chemotherapy followed by radiochemotherapy in pancreatic cancer M. Fiore (Italy), R. D’Angelillo, B. Floreno, P. Trecca, L. Trodella, A. Iurato, L. Trodella, R. Coppola, S. Ramella > Is stereotactic radiotherapy following radiochemotherapy useful in local advanced pancreatic cancer? G. Mattiucci, A. Nardangeli (Italy), L. Boldrini, M. Balducci, F. Cellini, > Significant heart dose reduction by deep inspiration breath hold for RT of esophageal cancer M. Dieters (The Netherlands), J.C. Beukema, A.C.M. Van den Bergh, E.W. Korevaar, N.M. Sijtsema, J.A. Langendijk, C.T. Muijs > Discrepancies between pathological data on nodal spread and the CTVs in RT for biliary tract cancer J. Socha (Poland), M. Michalak, G. Wołąkiewicz, L. Kępka S. Chiesa, G. Chiloiro, F. Deodato, N. Dinapoli, V. Frascino, M. Gambacorta, G. Macchia, A. Morganti, V. Valentini

PO-0696

PO-0697

PO-0698

PO-0699

PO-0700

PO-0701

POSTER Clinical track: Lower GI (colon, rectum, anus)

> Phase I trial evaluating panitumumab in combination with chemoradiotherapy for anal cancers

V. Vendrely (France), C. Lemanski, E. Le Prise, E. Maillard, X. Mirabel, G. Lledo, L. Dahan, A. Adenis, G. Paintaud, T. Lecomte, C. Levy-Piedbois, E. Terrebonne, V. Mammar, S. Manfredi, T. Aparicio

PO-0702

> Bowel dysfunction resulting from different treatment strategies in patients with rectal cancer.

POSTERS AND ELECTRONIC POSTERS | Programme and Exhibition Guide

180